Translational Research in Academia and Industry
暂无分享,去创建一个
[1] Patricia L. Harris,et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. , 2004, The New England journal of medicine.
[2] G. Giaccone,et al. EGFR inhibitors: what have we learned from the treatment of lung cancer? , 2005, Nature Clinical Practice Oncology.
[3] C. Lengauer,et al. Cancer drug discovery through collaboration , 2005, Nature Reviews Drug Discovery.
[4] P. Jänne,et al. Epidermal growth factor receptor mutations in patients with non-small cell lung cancer. , 2005, Cancer research.
[5] L. Rozamus,et al. Long-term pharmacologically regulated expression of erythropoietin in primates following AAV-mediated gene transfer. , 2005, Blood.
[6] K. Nakai,et al. [Controlling signal transduction with synthetic ligands]. , 2007, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme.
[7] S. Heimfeld,et al. Pharmacologically regulated Fas-mediated death of adoptively transferred T cells in a nonhuman primate model. , 2004, Blood.
[8] V. Rivera,et al. Regulated delivery of therapeutic proteins after in vivo somatic cell gene transfer. , 1999, Science.
[9] T. Clackson,et al. A Fas-based suicide switch in human T cells for the treatment of graft-versus-host disease. , 2001, Blood.
[10] T. Clackson,et al. Intravenous Safety and Pharmacokinetics of a Novel Dimerizer Drug, AP1903, in Healthy Volunteers , 2001, Journal of clinical pharmacology.
[11] C. von Kalle,et al. Pharmacologically regulated in vivo selection in a large animal. , 2002, Blood.
[12] S. Gabriel,et al. EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy , 2004, Science.